Local study participants contribute to the first Ebola vaccine distributed by WHO
May 24, 2018
As of Monday, May 21, 2018 an experimental Ebola vaccine developed by the pharmaceutical company Merck, is being used to contain an outbreak in the Democratic Republic of Congo.
In 2015, Coastal Carolina Research Center in Mt. Pleasant, SC conducted a clinical trial of this vaccine with Lowcountry volunteers participating and advancing its development.
Dr. Cynthia Strout, Medical Director of Coastal Carolina Research Center stated, “It is easy to get busy and not think how important the studies we do really are. We studied this Ebola vaccine three years ago and it’s a privilege to be a small part of helping fight this terrible disease.”
Below is the link to the Reuters story about the Congo outbreak.
Coastal Carolina Research Center is a locally owned and operated research center and will be conducting an anthrax vaccine study in the near future.
CCRC is located at 1156 Bowman Rd. Suite 102 Mt. Pleasant, SC
